IP Verse

Solid Pharmaceutical Composition Of Cytisine And Process For Preparation Thereof - EP2957280

The patent EP2957280 was granted to Aflofarm Farmacja Polska SP Z OO on Apr 17, 2019. The application was originally filed on Jun 17, 2015 under application number EP15001790A. The patent is currently recorded with a legal status of "Revoked".

EP2957280

AFLOFARM FARMACJA POLSKA SP Z OO
Application Number
EP15001790A
Filing Date
Jun 17, 2015
Status
Revoked
May 28, 2024
Grant Date
Apr 17, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ADAMSON JONESJan 17, 2020CARRIDGEADMISSIBLE
SOPHARMA ADJan 16, 2020SHENTOVAADMISSIBLE

Patent Citations (10) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP1586320
DESCRIPTIONPL184934B
DESCRIPTIONPL401676
DESCRIPTIONWO8302892
OPPOSITIONEP1586320
OPPOSITIONWO2014076680
OTHERPL220354B
SEARCHEP1586320
SEARCHEP2233134
SEARCHWO2014076680

Non-Patent Literature (NPL) Citations (17) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- MASHKOVSKY, M. D., MEDICINE REMEDIES, (1977), vol. 1, page 123-
OPPOSITION- "Calcium", R. C ROWE, Handbook of Pharmaceutical Excipients, Pharmaceutical Press, (20060000), pages 93 - 99 ;132- 135;188-191; 449-452, XP055674119-
OPPOSITION- Encyclopedia of Pharmaceutical Technology, (20070000), pages 3641 - 3683, XP055674129-
OPPOSITION- PIOTR TUTKA et al., "Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy", Pharmacol Rep, (20061100), vol. 58, no. 6, pages 777 - 798, XP055674085-
OPPOSITION- P. KIPPAX, "Particle size analysis", Pharmaceutical Technology Europe, (20090401), pages 1 - 4, URL: http://www.pharmtech.com/particle-size-analysis, XP055674127-
OPPOSITION- SRINIVASAN, "Selection of Excipients in Generic Formulations, Pharmaceutical Technology", Solid Dosage & Excipients, (20140400), URL: PharmTech.com, XP55674871-
OPPOSITION- SUN et al., "Particle Size Specifications for Solid Oral Dosage Forms: A Regulatory Perspective", American Pharmaceutical Review, (20100000), vol. 13, pages 1 - 7, XP055270559-
OPPOSITION- "Tablet formulation", Augsburger et al, Encyclopedia of Pharmaceutical Technology, Informa Healthcare, (20070000), pages 3641 - 3683, XP055674129-
OPPOSITION- V. KUKKAR et al., "Mixing and formulation of low dose drugs: underlying problems and solutions", Thai J. Pharm. Sci., (20081231), vol. 32, pages 43 - 58, XP055012249-
OPPOSITION- YALKOWSKY et al., "Particle Size and Content Uniformity", Pharm Research, vol. 7, no. 9, page 1990, XP003026219-
OPPOSITION- ZHENG et al., "Development of Low-Dose Solid Oral Tablets Using Direct Compression", Formulation and Analytical Development for Low-Dose Oral Drug Products, (20090300), XP002675413-
OPPOSITION- Z. SUN et al., "Particle Size Specifications for Solid Oral Dosage Forms: A Regulatory Perspective", American Pharmaceutical Review, (20100501), vol. 13, no. 4, pages 68 - 73, XP055270559-
OPPOSITION- JF. ETTER, "Cytisine for Smoking Cessation", Arch Intern Med, (20060814), vol. 166, no. 15, pages 1553 - 1559, XP055117158
OPPOSITION- ROHRS et al., "Particle Size Limits to Meet USP Content Uniformity Criteria for Tablets and Capsules", J. Pharm, Sci., (20060500), vol. 95, no. 5, doi:10.1002/jps.20587, XP055077685
OPPOSITION- R. WEST, W. ZATONSKI et al., "Placebo-Controlled Trial of Cytisine for Smoking Cessation", New Engl J Med, (20110929), vol. 365, no. 11, pages 1193 - 1200, XP055674090
OPPOSITION- ART. HAYWOOD et al., "Pharmaceutical excipients - where do we begin?", Aust. Prescr., (20110800), vol. 34, no. 4, pages 112 - 114, XP055674098
OTHER- Janicki et al, Textbook for pharmacy students, (19960000), page 160, 180, 692-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents